0.00
+0(+0.00%)
Currency In USD
Address
57 West 57th Street
New York City, NY 10019
United States of America
Phone
646 416 7912
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
36
First IPO Date
February 05, 2018
| Name | Title | Pay | Year Born |
| Dr. Dewan Fazlul Hoque Chowdhury Ph.D. | Chairman, Interim Chief Financial Officer, Chief Executive Officer, President and Principal Financial & Accounting Officer | 338,578 | 1973 |
| Ms. Samantha Sanders | Global Head of Digital Programs | 0 | N/A |
| Mr. Jay L. Warner M.B.A. | Head of U.S. Commercial Operations | 0 | N/A |
| Mr. Thomas Bendix Mortensen | Head of E.U. Commercial Operations & Marketing | 0 | N/A |
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.